Kent Imaging Appoints Healthcare Veteran as CEO
Kent Imaging announced today the appointment of seasoned medical imaging executive Pierre Lemire to the role of Chief Executive Officer. Mr. Lemire brings more than 30 years of experience in successfully launching new products to market. Prior to joining Kent Imaging, he co-founded Calgary Scientific and as President, led the company in becoming a global leader in medical imaging. He was also previously Chief Technology Officer for Autodesk, a Silicon Valley company. Kent founder Don Chapman will continue in his role as Executive Chairman assisting Mr. Lemire in launching the company’s new handheld imaging device.
Kent Imaging is a leading innovating company in the light-based imaging medical industry, excited to have Mr. Lemire onboard. “I’ve been involved in technology since 1983 when I was at university with the intention of getting a commerce degree, but pivoted and took computer science, learned how to program in basic, and have been building products ever since,” he stated.
About SnapshotNIR:
ACTIONABLE, ACCURATE DATA
THE POWER OF DIAGNOSTIC-DRIVEN WOUND CARE IS IN YOUR HANDS
Chronic wounds are a health problem with significant reductions in quality of life and can have devastating consequences such as limb amputations and premature death. Current diagnostic tools to assess tissue health are either costly or difficult to employ (or both), and visual assessment alone is not adequate to see the whole picture. Historically there have been no easy or cost-effective ways to directly assess tissue viability. SnapshotNIR is a medical imaging device that visualizes and maps tissue oxygen saturation in the capillary network.
SnapshotNIR has features that expand the application of near-infrared spectroscopy (NIRS) to include imaging on almost all skin tones, advancing tissue assessment for physicians and patients. The device measures tissue oxygen saturation (StO2), oxyhemoglobin and deoxyhemoglobin in nearly all individuals at any location on the body. With the unique Hemoglobin View, providers can track the wound healing trends, to ensure that oxyhemoglobin increases, while deoxyhemoglobin decreases.
Read about the current stage of the device.
About Kent Imaging:
Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in near-infrared tissue oxygenation imaging, which develops, manufactures, and markets medical technology that supports real-time decision-making in wound care, vascular and surgical subspecialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally.